Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus

Journal of the Medical Association of Thailand

Volumn 87, Issue 11, 2004, Pages 1374-1379

  Uaratanawong, Somchai ^a   Deesomchok, Utis ^b   Hiransuttikul, Narin ^b   Uaratanawong, Somsri ^a  

^a Bangkok Metropolitan Administration   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bone mineral density; Glucocorticoids; Systemic lupus erythematosus

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; PREMENOPAUSE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREMENOPAUSE; TIME FACTORS;

EID: 13744258592     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kallar AA, Fataas AB, Jeqsop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1726-34.
2. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 274-6.
3. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: an update. Arthritis Care Res 1995; 8: 137-45.
4. Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 2003; 30: 2365-8.
5. Pons F, Peris P, Guanabens N, Font J, Huguet M, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. Br J Rheumatol 1995; 34: 742-6.
6. Kipen Y, Buchbinder R, Strauss BJG, Forbes A, Littlejohn G, et al. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of glucocorticoids. J Rheumatol 1997; 24: 1922-9.
7. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer J-P, et al. Trabecularand cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 244-7.
8. Sels F, Dequeker J, Verwilghen J, Mbuyi-Muamba J-M. Viewpoint SLE and osteoporosis: dependence and/ or independence on glucocorticoids. Lupus 1996; 5: 89-92.
9. Formiga F, Nolla JM, Moga I, Roig-Escofet D. Sequential study of bone mineral density in patients with systemic lupus erythematosus [letter]. Ann Rheum Dis 1996; 55: 857.
10. Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, et al. Three year follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 1999; 26: 310-7.
11. Tan Em, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-5.
12. Steinbrocker O, Traeger CH, Batterman RE. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 1947; 140: 659-7.
13. Bombardier C, Gladman DD, Urowiz MB, Caron D, Chang CH. Deviation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
14. Katz JD, Senecal J-L, Rivest C, Goulet JR, Rothfield N. A simple severity of disease index for SLE. Lupus 1993; 2: 119-23.
15. Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, et al. Effect of calcitrol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. J Rheumatol 2001; 27: 1759-65.
16. Gough AKS, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344: 23-7.
17. Shenstone BD, Mahmoud A, Woodward R, Elwins D, Palmer R, et al. Longituidinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 1994; 33: 541-5.
18. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations in estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1195-8.
19. Coimbra IB and Costallat LT. Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy. Joint Bone Spine 2003; 70: 4-5.
20. Lukert BP, Raisz LG. Glucocorticoid - induced osteoporosis: pathogenesis and management. Ann Int Med 1993; 112: 352-64.
21. Castro TC, Terreri MT, Szejnfeld VL, Castro CH, Fisberg M, et al. Bone mineral density in systemic lupus erythematosus. Braz J Med Bio Res 2002; 35: 1159-63.
22. Manolagas SC, RL Jika. Bone marrow, cytokines, and bone remodeling. Emerging insights into pathophysiology of osteoporosis. N Eng J Med 1995; 332: 305-11.
23. Al-Janadi M, Al-Balla S, Al-Dallan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13: 58-67.
24. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147: 117-23.